BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27678053)

  • 21. The evolution of evolvability in genetic linkage patterns.
    Pepper JW
    Biosystems; 2003 May; 69(2-3):115-26. PubMed ID: 12689725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic effects on mandibular morphology II: differential epistasis and genetic variation in morphological integration.
    Cheverud JM; Ehrich TH; Vaughn TT; Koreishi SF; Linsey RB; Pletscher LS
    J Exp Zool B Mol Dev Evol; 2004 Sep; 302(5):424-35. PubMed ID: 15384169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The causes of epistasis.
    de Visser JA; Cooper TF; Elena SF
    Proc Biol Sci; 2011 Dec; 278(1725):3617-24. PubMed ID: 21976687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epistasis and entrenchment of drug resistance in HIV-1 subtype B.
    Biswas A; Haldane A; Arnold E; Levy RM
    Elife; 2019 Oct; 8():. PubMed ID: 31591964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation in pleiotropy: differential epistasis as a source of variation in the allometric relationship between long bone lengths and body weight.
    Pavlicev M; Kenney-Hunt JP; Norgard EA; Roseman CC; Wolf JB; Cheverud JM
    Evolution; 2008 Jan; 62(1):199-213. PubMed ID: 18005158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissection of complex gene expression using the combined analysis of pleiotropy and epistasis.
    Philip VM; Tyler AL; Carter GW
    Pac Symp Biocomput; 2014; ():200-11. PubMed ID: 24297548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.
    van der Hoek L; Back N; Jebbink MF; de Ronde A; Bakker M; Jurriaans S; Reiss P; Parkin N; Berkhout B
    J Virol; 2005 Mar; 79(6):3536-43. PubMed ID: 15731248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.
    Pattery T; Verlinden Y; De Wolf H; Nauwelaers D; Van Baelen K; Van Houtte M; Mc Kenna P; Villacian J
    Intervirology; 2012; 55(2):138-46. PubMed ID: 22286884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the evolution of genetic architecture: A continuum of alleles model with pairwise AxA epistasis.
    Wagner GP; Mezey J
    J Theor Biol; 2000 Mar; 203(2):163-75. PubMed ID: 10704300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary quantitative genetics of nonlinear developmental systems.
    Morrissey MB
    Evolution; 2015 Aug; 69(8):2050-66. PubMed ID: 26174586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comment on "Evidence for positive epistasis in HIV-1".
    Wang K; Mittler JE; Samudrala R
    Science; 2006 May; 312(5775):848; author reply 848. PubMed ID: 16690844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in adaptability and pleiotropy in budding yeast.
    Jerison ER; Kryazhimskiy S; Mitchell JK; Bloom JS; Kruglyak L; Desai MM
    Elife; 2017 Aug; 6():. PubMed ID: 28826486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mutation matrix and the evolution of evolvability.
    Jones AG; Arnold SJ; Bürger R
    Evolution; 2007 Apr; 61(4):727-45. PubMed ID: 17439608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
    Miller V; Larder BA
    Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong Selection Significantly Increases Epistatic Interactions in the Long-Term Evolution of a Protein.
    Gupta A; Adami C
    PLoS Genet; 2016 Mar; 12(3):e1005960. PubMed ID: 27028897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A model of developmental evolution: selection, pleiotropy and compensation.
    Pavlicev M; Wagner GP
    Trends Ecol Evol; 2012 Jun; 27(6):316-22. PubMed ID: 22385978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
    Brandin E; Lindborg L; Gyllensten K; Broström C; Hagberg L; Gisslen M; Tuvesson B; Blaxhult A; Albert J
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):543-50. PubMed ID: 12908931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directional selection can drive the evolution of modularity in complex traits.
    Melo D; Marroig G
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):470-5. PubMed ID: 25548154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Learning multiple evolutionary pathways from cross-sectional data.
    Beerenwinkel N; Rahnenführer J; Däumer M; Hoffmann D; Kaiser R; Selbig J; Lengauer T
    J Comput Biol; 2005; 12(6):584-98. PubMed ID: 16108705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.